Neurosense Therapeutics Ltd
NRSN1.215USD
+0.135+12.50%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
28.22MMarket Cap
LossP/E TTM
Neurosense Therapeutics Ltd
1.215
+0.135+12.50%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
Operating expenses
-19.76%2.11M
-10.09%3.03M
0.10%2.99M
-2.72%3.29M
-20.88%2.63M
-6.13%3.37M
-8.36%2.99M
--3.38M
--3.32M
--3.59M
--3.26M
R&D expenses
-25.48%1.16M
-19.87%1.57M
1.62%1.88M
26.81%1.96M
-8.68%1.56M
4.71%1.96M
42.90%1.85M
--1.54M
--1.71M
--1.87M
--1.30M
Operating profit
19.76%-2.11M
10.09%-3.03M
-0.10%-2.99M
2.72%-3.29M
20.88%-2.63M
6.13%-3.37M
8.36%-2.99M
---3.38M
---3.32M
---3.59M
---3.26M
Net non-operating interest income (expenses)
Non-operating interest income
----
--2.17M
----
64.08%338.00K
579.40%2.28M
----
-88.29%67.00K
--206.00K
--335.00K
--144.00K
--572.00K
Non-operating interest expense
--41.00K
----
--2.41M
--1.00K
----
688.57%276.00K
----
----
--10.00K
--35.00K
--23.00K
Gains from sale of securities
----
----
----
----
----
----
----
--23.00K
----
----
----
Income before tax
-513.71%-2.15M
76.49%-857.00K
-84.82%-5.40M
6.35%-2.95M
88.31%-350.00K
-4.74%-3.65M
-7.70%-2.92M
---3.15M
---2.99M
---3.48M
---2.71M
Income after tax
-513.71%-2.15M
76.49%-857.00K
-84.82%-5.40M
6.35%-2.95M
88.31%-350.00K
-4.74%-3.65M
-7.70%-2.92M
---3.15M
---2.99M
---3.48M
---2.71M
Net income from continuous operations
-513.71%-2.15M
76.49%-857.00K
-84.82%-5.40M
6.35%-2.95M
88.31%-350.00K
-4.74%-3.65M
-7.70%-2.92M
---3.15M
---2.99M
---3.48M
---2.71M
Net income attributable to controlling interests
-513.71%-2.15M
76.49%-857.00K
-84.82%-5.40M
6.35%-2.95M
88.31%-350.00K
-4.74%-3.65M
-7.70%-2.92M
---3.15M
---2.99M
---3.48M
---2.71M
Net income attributable to common shareholders
-513.71%-2.15M
76.49%-857.00K
-84.82%-5.40M
6.35%-2.95M
88.31%-350.00K
-4.74%-3.65M
-7.70%-2.92M
---3.15M
---2.99M
---3.48M
---2.71M
Basic earnings per share
-336.29%-0.11
84.51%-0.05
-41.39%-0.35
35.44%-0.17
90.08%-0.03
-1.61%-0.31
-0.47%-0.25
---0.27
---0.26
---0.30
---0.25
Diluted earnings per share
-336.29%-0.11
84.51%-0.05
-41.39%-0.35
35.44%-0.17
90.08%-0.03
-1.61%-0.31
-0.47%-0.25
---0.27
---0.26
---0.30
---0.25
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
